<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Tako-Tsubo <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> (TTC) occurs particularly in post-menopausal women, being precipitated in many cases by severe <z:e sem="disease" ids="C0086209" disease_type="Mental or Behavioral Dysfunction" abbrv="">emotional stress</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We describe six patients in whom TTC occurred in association with therapeutic ingestion or overdose of the <z:chebi fb="19" ids="28790">serotonin</z:chebi>/<z:chebi fb="15" ids="33569">noradrenaline</z:chebi> reuptake inhibitor <z:chebi fb="0" ids="9943">venlafaxine</z:chebi>, or its metabolite desvenlafaxine </plain></SENT>
<SENT sid="2" pm="."><plain>Importantly, two of the six cases were not post-menopausal women </plain></SENT>
<SENT sid="3" pm="."><plain>An increased risk of TTC may account for some of the reported cardiovascular adverse effects of <z:chebi fb="0" ids="9943">venlafaxine</z:chebi> and similar agents </plain></SENT>
</text></document>